Ask AI
ProCE Banner Activity

CE

Listen Up: Time to Prioritize RSV Vaccination for Adults

Podcast Episodes

In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV.

Registered Nurses: 1.00 Nursing contact hour

Released: June 09, 2025

Expiration: June 08, 2026

Share

Provided by

Provided by the American Association of Nurse Practitioners (AANP) in partnership with Practicing Clinicians Exchange (PCE)

ProCE Banner

Supporters

This educational activity is supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Partners

Practicing Clinicians Exchange, LLC

ProCE Banner

Target Audience

This activity is intended for nurse practitioners practicing in primary and specialty care who are involved in the care of adults in need of RSV vaccination.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of nurse practitioners regarding strategies to optimize uptake of RSV vaccination in adults.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Counsel vaccine candidates on risk factors for severe RSV disease

  • Incorporate the latest RSV vaccine recommendations into clinical practice

  • Identify and implement strategies to improve RSV vaccine uptake across diverse populations

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP, FAAN: speaker: Pfizer; advisor: Moderna, Pfizer; consultant: Valneva, VaxCare.

Audrey Stevenson, PhD, MPH, MSN, FNP-BC: speaker: GlaxoSmithKline, Sanofi, Seqirus; advisor: Sanofi.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

All relevant financial relationships have been mitigated.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 09, 2025, through June 08, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Nursing Continuing Professional Development

This activity is approved for 1.0 contact hour(s) of continuing education by the American Association of Nurse Practitioners® (AANP). Activity ID# 25057175. This activity was planned in accordance with AANP Accreditation Standards and Policies.